Both are antihistamines. Here is how Claritin and Allegra compare on class, mechanism, dosing, approval and supply.
At a glance
ClaritinLoratadine
AllegraFexofenadine
Brand names
Claritin
Allegra / Telfast
Drug class
Second-generation antihistamine
Second-generation antihistamine
Route
Oral
Not listed
Marketed by
Bayer
Sanofi
First FDA approval
12 Apr 1993
25 Jul 1996
US shortage
Not listed
Not listed
Key differences
Same class. Both Claritin and Allegra are antihistamines, so they work through the same broad mechanism. Differences between them tend to be about dosing, route, how selective they are, and side effects rather than what they target.
Time on the market. Claritin was first approved by the FDA in 1993, Allegra in 1996. That gives Claritin roughly 3 more years of real-world use and long-term safety data.
Who markets them. Claritin is marketed by Bayer; Allegra by Sanofi.
Same drug, more than one brand. Fexofenadine is sold as Allegra / Telfast — the same active ingredient marketed under different brand names, typically for different approved uses or doses.
What each one treats
ClaritinLoratadine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
AllegraFexofenadine
An oral daily allergy medication used to relieve sneezing, runny nose, and itchy eyes.
This is not medical advice, and not a recommendation of one drug over the other.
Which medicine is right for a given person depends on their diagnosis, other conditions, other medicines, kidney and liver function, pregnancy, and cost or reimbursement — none of which this page knows. Two drugs in the same class are not automatically interchangeable. Never start, stop or switch a prescription medicine on the basis of a web page; that decision belongs to you and your clinician or pharmacist.
Class and summary text is written by the Priya Life Science editorial team. Label, mechanism, route, manufacturer and approval data come from the U.S. FDA via the openFDA API; shortage status from the FDA Drug Shortage Database. Approvals, indications and brand names differ between the US, EU/Ireland (EMA/HPRA) and other regions — a drug approved in one may not be approved, or may carry a different name, in another.
We value your privacy
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.